A practical guide to building a CTMS business case focusing on ROI, operational efficiency, visibility, accountability, compliance, and risk reduction. Learn how clinical research organizations, academic medical centers, universities, CROs, and research institutions can quantify the cost of manual trial management and evaluate how a modern CTMS can improve study start-up, site performance, audit readiness, and research operations nationwide.

Secure research collaboration is critical for universities, hospitals, CROs, biotech, and pharmaceutical organizations across Canada and the United States. As clinical trial data, IP, and regulatory information are shared, trust is the foundation. This article explores why secure research collaboration platforms matter and how myLaminin enables SOC 2 Type II compliant, patented collaboration across North America while protecting sensitive research data and accelerating discov

Five years ago, myLaminin began with a single idea. Today, it has evolved into a connected research ecosystem supporting the complete research lifecycle—from grant submission through publication. Discover how one conversation with a Canadian U15 university transformed our vision, how researchers co-designed our platform, and how myLaminin became a sovereign Research Data Management (RDM) and Clinical Trial Management System (CTMS) built for active science.

The new ICH E6(R3) guidelines are transforming clinical research worldwide, requiring Quality-by-Design, risk-based oversight, and validated digital systems. Discover how myLaminin's co-designed Clinical Trial Operations (CTOps) and CTMS platform helps research teams, principal investigators, administrators, and compliance professionals streamline operations, strengthen data integrity, improve audit readiness, and meet evolving global regulatory requirements with confidence.